Global Liver Diseases Treatment Market Size, Status and Forecast 2024-2031

Report ID: 920387 | Published Date: Sep 2024 | No. of Page: 128 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Liver Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemotherapy Drugs
        1.2.3 Targeted Therapy
        1.2.4 Anti-Viral Drugs
        1.2.5 Immunoglobulins
        1.2.6 Corticosteroids
        1.2.7 Vaccines
        1.2.8 Anti-Rejection Drugs/Immunosuppressant
    1.3 Market by Application
        1.3.1 Global Liver Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer
        1.3.3 Hepatitis
        1.3.4 Cirrhosis
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Liver Diseases Treatment Market Perspective (2016-2027)
    2.2 Liver Diseases Treatment Growth Trends by Regions
        2.2.1 Liver Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Liver Diseases Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Liver Diseases Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Liver Diseases Treatment Industry Dynamic
        2.3.1 Liver Diseases Treatment Market Trends
        2.3.2 Liver Diseases Treatment Market Drivers
        2.3.3 Liver Diseases Treatment Market Challenges
        2.3.4 Liver Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Liver Diseases Treatment Players by Revenue
        3.1.1 Global Top Liver Diseases Treatment Players by Revenue (2016-2021)
        3.1.2 Global Liver Diseases Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Liver Diseases Treatment Revenue
    3.4 Global Liver Diseases Treatment Market Concentration Ratio
        3.4.1 Global Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Liver Diseases Treatment Revenue in 2020
    3.5 Liver Diseases Treatment Key Players Head office and Area Served
    3.6 Key Players Liver Diseases Treatment Product Solution and Service
    3.7 Date of Enter into Liver Diseases Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Diseases Treatment Breakdown Data by Type
    4.1 Global Liver Diseases Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Liver Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Liver Diseases Treatment Breakdown Data by Application
    5.1 Global Liver Diseases Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Liver Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Liver Diseases Treatment Market Size (2016-2027)
    6.2 North America Liver Diseases Treatment Market Size by Type
        6.2.1 North America Liver Diseases Treatment Market Size by Type (2016-2021)
        6.2.2 North America Liver Diseases Treatment Market Size by Type (2022-2027)
        6.2.3 North America Liver Diseases Treatment Market Size by Type (2016-2027)
    6.3 North America Liver Diseases Treatment Market Size by Application
        6.3.1 North America Liver Diseases Treatment Market Size by Application (2016-2021)
        6.3.2 North America Liver Diseases Treatment Market Size by Application (2022-2027)
        6.3.3 North America Liver Diseases Treatment Market Size by Application (2016-2027)
    6.4 North America Liver Diseases Treatment Market Size by Country
        6.4.1 North America Liver Diseases Treatment Market Size by Country (2016-2021)
        6.4.2 North America Liver Diseases Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Liver Diseases Treatment Market Size (2016-2027)
    7.2 Europe Liver Diseases Treatment Market Size by Type
        7.2.1 Europe Liver Diseases Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Liver Diseases Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Liver Diseases Treatment Market Size by Type (2016-2027)
    7.3 Europe Liver Diseases Treatment Market Size by Application
        7.3.1 Europe Liver Diseases Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Liver Diseases Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Liver Diseases Treatment Market Size by Application (2016-2027)
    7.4 Europe Liver Diseases Treatment Market Size by Country
        7.4.1 Europe Liver Diseases Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Liver Diseases Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Liver Diseases Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Liver Diseases Treatment Market Size by Type
        8.2.1 Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Liver Diseases Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Liver Diseases Treatment Market Size by Application
        8.3.1 Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Liver Diseases Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Liver Diseases Treatment Market Size by Region
        8.4.1 Asia-Pacific Liver Diseases Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Liver Diseases Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Liver Diseases Treatment Market Size (2016-2027)
    9.2 Latin America Liver Diseases Treatment Market Size by Type
        9.2.1 Latin America Liver Diseases Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Liver Diseases Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Liver Diseases Treatment Market Size by Type (2016-2027)
    9.3 Latin America Liver Diseases Treatment Market Size by Application
        9.3.1 Latin America Liver Diseases Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Liver Diseases Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Liver Diseases Treatment Market Size by Application (2016-2027)
    9.4 Latin America Liver Diseases Treatment Market Size by Country
        9.4.1 Latin America Liver Diseases Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Liver Diseases Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Liver Diseases Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Liver Diseases Treatment Market Size by Type
        10.2.1 Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Liver Diseases Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Liver Diseases Treatment Market Size by Application
        10.3.1 Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Liver Diseases Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Liver Diseases Treatment Market Size by Country
        10.4.1 Middle East & Africa Liver Diseases Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Liver Diseases Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Liver Diseases Treatment Introduction
        11.1.4 Abbott Laboratories Revenue in Liver Diseases Treatment Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Bayer Schering
        11.2.1 Bayer Schering Company Details
        11.2.2 Bayer Schering Business Overview
        11.2.3 Bayer Schering Liver Diseases Treatment Introduction
        11.2.4 Bayer Schering Revenue in Liver Diseases Treatment Business (2016-2021)
        11.2.5 Bayer Schering Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Details
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Liver Diseases Treatment Introduction
        11.3.4 Eli Lilly Revenue in Liver Diseases Treatment Business (2016-2021)
        11.3.5 Eli Lilly Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Liver Diseases Treatment Introduction
        11.4.4 Merck Revenue in Liver Diseases Treatment Business (2016-2021)
        11.4.5 Merck Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Liver Diseases Treatment Introduction
        11.5.4 Novartis Revenue in Liver Diseases Treatment Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Liver Diseases Treatment Introduction
        11.6.4 Pfizer Revenue in Liver Diseases Treatment Business (2016-2021)
        11.6.5 Pfizer Recent Development
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Roche Business Overview
        11.7.3 Roche Liver Diseases Treatment Introduction
        11.7.4 Roche Revenue in Liver Diseases Treatment Business (2016-2021)
        11.7.5 Roche Recent Development
    11.8 Sanofi-Aventis
        11.8.1 Sanofi-Aventis Company Details
        11.8.2 Sanofi-Aventis Business Overview
        11.8.3 Sanofi-Aventis Liver Diseases Treatment Introduction
        11.8.4 Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2016-2021)
        11.8.5 Sanofi-Aventis Recent Development
    11.9 Takeda Pharmaceutical
        11.9.1 Takeda Pharmaceutical Company Details
        11.9.2 Takeda Pharmaceutical Business Overview
        11.9.3 Takeda Pharmaceutical Liver Diseases Treatment Introduction
        11.9.4 Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2016-2021)
        11.9.5 Takeda Pharmaceutical Recent Development
    11.10 Zydus Pharmaceuticals
        11.10.1 Zydus Pharmaceuticals Company Details
        11.10.2 Zydus Pharmaceuticals Business Overview
        11.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Introduction
        11.10.4 Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
        11.10.5 Zydus Pharmaceuticals Recent Development
    11.11 Glaxosmithkline
        11.11.1 Glaxosmithkline Company Details
        11.11.2 Glaxosmithkline Business Overview
        11.11.3 Glaxosmithkline Liver Diseases Treatment Introduction
        11.11.4 Glaxosmithkline Revenue in Liver Diseases Treatment Business (2016-2021)
        11.11.5 Glaxosmithkline Recent Development
    11.12 Bristol-Myers Squibb
        11.12.1 Bristol-Myers Squibb Company Details
        11.12.2 Bristol-Myers Squibb Business Overview
        11.12.3 Bristol-Myers Squibb Liver Diseases Treatment Introduction
        11.12.4 Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2016-2021)
        11.12.5 Bristol-Myers Squibb Recent Development
    11.13 General Electric
        11.13.1 General Electric Company Details
        11.13.2 General Electric Business Overview
        11.13.3 General Electric Liver Diseases Treatment Introduction
        11.13.4 General Electric Revenue in Liver Diseases Treatment Business (2016-2021)
        11.13.5 General Electric Recent Development
    11.14 Koninklijke Philips
        11.14.1 Koninklijke Philips Company Details
        11.14.2 Koninklijke Philips Business Overview
        11.14.3 Koninklijke Philips Liver Diseases Treatment Introduction
        11.14.4 Koninklijke Philips Revenue in Liver Diseases Treatment Business (2016-2021)
        11.14.5 Koninklijke Philips Recent Development
    11.15 Siemens
        11.15.1 Siemens Company Details
        11.15.2 Siemens Business Overview
        11.15.3 Siemens Liver Diseases Treatment Introduction
        11.15.4 Siemens Revenue in Liver Diseases Treatment Business (2016-2021)
        11.15.5 Siemens Recent Development
    11.16 Canon Medical Systems Corp
        11.16.1 Canon Medical Systems Corp Company Details
        11.16.2 Canon Medical Systems Corp Business Overview
        11.16.3 Canon Medical Systems Corp Liver Diseases Treatment Introduction
        11.16.4 Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2016-2021)
        11.16.5 Canon Medical Systems Corp Recent Development
    11.17 Hitachi
        11.17.1 Hitachi Company Details
        11.17.2 Hitachi Business Overview
        11.17.3 Hitachi Liver Diseases Treatment Introduction
        11.17.4 Hitachi Revenue in Liver Diseases Treatment Business (2016-2021)
        11.17.5 Hitachi Recent Development
    11.18 Elekta
        11.18.1 Elekta Company Details
        11.18.2 Elekta Business Overview
        11.18.3 Elekta Liver Diseases Treatment Introduction
        11.18.4 Elekta Revenue in Liver Diseases Treatment Business (2016-2021)
        11.18.5 Elekta Recent Development
    11.18 Neusoft Corporation
        11.25.1 Neusoft Corporation Company Details
        11.25.2 Neusoft Corporation Business Overview
        11.25.3 Neusoft Corporation Liver Diseases Treatment Introduction
        11.25.4 Neusoft Corporation Revenue in Liver Diseases Treatment Business (2016-2021)
        11.25.5 Neusoft Corporation Recent Development
    11.20 Samsung Healthcare
        11.20.1 Samsung Healthcare Company Details
        11.20.2 Samsung Healthcare Business Overview
        11.20.3 Samsung Healthcare Liver Diseases Treatment Introduction
        11.20.4 Samsung Healthcare Revenue in Liver Diseases Treatment Business (2016-2021)
        11.20.5 Samsung Healthcare Recent Development
    11.21 BPL Medical Technologies
        11.21.1 BPL Medical Technologies Company Details
        11.21.2 BPL Medical Technologies Business Overview
        11.21.3 BPL Medical Technologies Liver Diseases Treatment Introduction
        11.21.4 BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2016-2021)
        11.21.5 BPL Medical Technologies Recent Development
    11.22 Cura Healthcare
        11.22.1 Cura Healthcare Company Details
        11.22.2 Cura Healthcare Business Overview
        11.22.3 Cura Healthcare Liver Diseases Treatment Introduction
        11.22.4 Cura Healthcare Revenue in Liver Diseases Treatment Business (2016-2021)
        11.22.5 Cura Healthcare Recent Development
    11.23 Angion Biomedica
        11.23.1 Angion Biomedica Company Details
        11.23.2 Angion Biomedica Business Overview
        11.23.3 Angion Biomedica Liver Diseases Treatment Introduction
        11.23.4 Angion Biomedica Revenue in Liver Diseases Treatment Business (2016-2021)
        11.23.5 Angion Biomedica Recent Development
    11.24 Achillion Pharmaceuticals
        11.24.1 Achillion Pharmaceuticals Company Details
        11.24.2 Achillion Pharmaceuticals Business Overview
        11.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Introduction
        11.24.4 Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
        11.24.5 Achillion Pharmaceuticals Recent Development
    11.25 Gilead Sciences
        11.25.1 Gilead Sciences Company Details
        11.25.2 Gilead Sciences Business Overview
        11.25.3 Gilead Sciences Liver Diseases Treatment Introduction
        11.25.4 Gilead Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
        11.25.5 Gilead Sciences Recent Development
    11.26 LG Life Sciences
        11.26.1 LG Life Sciences Company Details
        11.26.2 LG Life Sciences Business Overview
        11.26.3 LG Life Sciences Liver Diseases Treatment Introduction
        11.26.4 LG Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
        11.26.5 LG Life Sciences Recent Development
    11.27 Verva Pharmaceuticals
        11.27.1 Verva Pharmaceuticals Company Details
        11.27.2 Verva Pharmaceuticals Business Overview
        11.27.3 Verva Pharmaceuticals Liver Diseases Treatment Introduction
        11.27.4 Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
        11.27.5 Verva Pharmaceuticals Recent Development
    11.28 Shenzhen Kangtai Biological Products
        11.28.1 Shenzhen Kangtai Biological Products Company Details
        11.28.2 Shenzhen Kangtai Biological Products Business Overview
        11.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Introduction
        11.28.4 Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2016-2021)
        11.28.5 Shenzhen Kangtai Biological Products Recent Development
    11.29 Raptor Pharmaceuticals
        11.29.1 Raptor Pharmaceuticals Company Details
        11.29.2 Raptor Pharmaceuticals Business Overview
        11.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Introduction
        11.29.4 Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
        11.29.5 Raptor Pharmaceuticals Recent Development
    11.30 ProMetic Life Sciences
        11.30.1 ProMetic Life Sciences Company Details
        11.30.2 ProMetic Life Sciences Business Overview
        11.30.3 ProMetic Life Sciences Liver Diseases Treatment Introduction
        11.30.4 ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
        11.30.5 ProMetic Life Sciences Recent Development
    11.31 Phenex Pharmaceuticals
        11.31.1 Phenex Pharmaceuticals Company Details
        11.31.2 Phenex Pharmaceuticals Business Overview
        11.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Introduction
        11.31.4 Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
        11.31.5 Phenex Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Anti-Viral Drugs
    Table 5. Key Players of Immunoglobulins
    Table 6. Key Players of Corticosteroids
    Table 7. Key Players of Vaccines
    Table 8. Key Players of Anti-Rejection Drugs/Immunosuppressant
    Table 9. Global Liver Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Liver Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Liver Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Liver Diseases Treatment Market Share by Regions (2016-2021)
    Table 13. Global Liver Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Liver Diseases Treatment Market Share by Regions (2022-2027)
    Table 15. Liver Diseases Treatment Market Trends
    Table 16. Liver Diseases Treatment Market Drivers
    Table 17. Liver Diseases Treatment Market Challenges
    Table 18. Liver Diseases Treatment Market Restraints
    Table 19. Global Liver Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Liver Diseases Treatment Market Share by Players (2016-2021)
    Table 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Treatment as of 2020)
    Table 22. Ranking of Global Top Liver Diseases Treatment Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Liver Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Liver Diseases Treatment Product Solution and Service
    Table 26. Date of Enter into Liver Diseases Treatment Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Liver Diseases Treatment Revenue Market Share by Type (2016-2021)
    Table 30. Global Liver Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Liver Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Liver Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Liver Diseases Treatment Revenue Market Share by Application (2016-2021)
    Table 34. Global Liver Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Liver Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Liver Diseases Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Liver Diseases Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Abbott Laboratories Company Details
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Liver Diseases Treatment Product
    Table 69. Abbott Laboratories Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 70. Abbott Laboratories Recent Development
    Table 71. Bayer Schering Company Details
    Table 72. Bayer Schering Business Overview
    Table 73. Bayer Schering Liver Diseases Treatment Product
    Table 74. Bayer Schering Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 75. Bayer Schering Recent Development
    Table 76. Eli Lilly Company Details
    Table 77. Eli Lilly Business Overview
    Table 78. Eli Lilly Liver Diseases Treatment Product
    Table 79. Eli Lilly Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 80. Eli Lilly Recent Development
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Liver Diseases Treatment Product
    Table 84. Merck Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 85. Merck Recent Development
    Table 86. Novartis Company Details
    Table 87. Novartis Business Overview
    Table 88. Novartis Liver Diseases Treatment Product
    Table 89. Novartis Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 90. Novartis Recent Development
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer Liver Diseases Treatment Product
    Table 94. Pfizer Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. Roche Company Details
    Table 97. Roche Business Overview
    Table 98. Roche Liver Diseases Treatment Product
    Table 99. Roche Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 100. Roche Recent Development
    Table 101. Sanofi-Aventis Company Details
    Table 102. Sanofi-Aventis Business Overview
    Table 103. Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 104. Sanofi-Aventis Recent Development
    Table 105. Takeda Pharmaceutical Company Details
    Table 106. Takeda Pharmaceutical Business Overview
    Table 107. Takeda Pharmaceutical Liver Diseases Treatment Product
    Table 108. Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 109. Takeda Pharmaceutical Recent Development
    Table 110. Zydus Pharmaceuticals Company Details
    Table 111. Zydus Pharmaceuticals Business Overview
    Table 112. Zydus Pharmaceuticals Liver Diseases Treatment Product
    Table 113. Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 114. Zydus Pharmaceuticals Recent Development
    Table 115. Glaxosmithkline Company Details
    Table 116. Glaxosmithkline Business Overview
    Table 117. Glaxosmithkline Liver Diseases Treatment Product
    Table 118. Glaxosmithkline Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 119. Glaxosmithkline Recent Development
    Table 120. Bristol-Myers Squibb Company Details
    Table 121. Bristol-Myers Squibb Business Overview
    Table 122. Bristol-Myers Squibb Liver Diseases Treatment Product
    Table 123. Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 124. Bristol-Myers Squibb Recent Development
    Table 125. General Electric Company Details
    Table 126. General Electric Business Overview
    Table 127. General Electric Liver Diseases Treatment Product
    Table 128. General Electric Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 129. General Electric Recent Development
    Table 130. Koninklijke Philips Company Details
    Table 131. Koninklijke Philips Business Overview
    Table 132. Koninklijke Philips Liver Diseases Treatment Product
    Table 133. Koninklijke Philips Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 134. Koninklijke Philips Recent Development
    Table 135. Siemens Company Details
    Table 136. Siemens Business Overview
    Table 137. Siemens Liver Diseases Treatment Product
    Table 138. Siemens Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 139. Siemens Recent Development
    Table 140. Canon Medical Systems Corp Company Details
    Table 141. Canon Medical Systems Corp Business Overview
    Table 142. Canon Medical Systems Corp Liver Diseases Treatment Product
    Table 143. Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 144. Canon Medical Systems Corp Recent Development
    Table 145. Hitachi Company Details
    Table 146. Hitachi Business Overview
    Table 147. Hitachi Liver Diseases Treatment Product
    Table 148. Hitachi Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 149. Hitachi Recent Development
    Table 150. Elekta Company Details
    Table 151. Elekta Business Overview
    Table 152. Elekta Liver Diseases Treatment Product
    Table 153. Elekta Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 154. Elekta Recent Development
    Table 155. Neusoft Corporation Company Details
    Table 156. Neusoft Corporation Business Overview
    Table 157. Neusoft Corporation Liver Diseases Treatment Product
    Table 158. Neusoft Corporation Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 159. Neusoft Corporation Recent Development
    Table 160. Samsung Healthcare Company Details
    Table 161. Samsung Healthcare Business Overview
    Table 162. Samsung Healthcare Liver Diseases Treatment Product
    Table 163. Samsung Healthcare Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 164. Samsung Healthcare Recent Development
    Table 165. BPL Medical Technologies Company Details
    Table 166. BPL Medical Technologies Business Overview
    Table 167. BPL Medical Technologies Liver Diseases Treatment Product
    Table 168. BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 169. BPL Medical Technologies Recent Development
    Table 170. Cura Healthcare Company Details
    Table 171. Cura Healthcare Business Overview
    Table 172. Cura Healthcare Liver Diseases Treatment Product
    Table 173. Cura Healthcare Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 174. Cura Healthcare Recent Development
    Table 175. Angion Biomedica Company Details
    Table 176. Angion Biomedica Business Overview
    Table 177. Angion Biomedica Liver Diseases Treatment Product
    Table 178. Angion Biomedica Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 179. Angion Biomedica Recent Development
    Table 180. Achillion Pharmaceuticals Company Details
    Table 181. Achillion Pharmaceuticals Business Overview
    Table 182. Achillion Pharmaceuticals Liver Diseases TreatmentProduct
    Table 183. Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 184. Achillion Pharmaceuticals Recent Development
    Table 185. Gilead Sciences Company Details
    Table 186. Gilead Sciences Business Overview
    Table 187. Gilead Sciences Liver Diseases Treatment Product
    Table 188. Gilead Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 189. Gilead Sciences Recent Development
    Table 190. LG Life Sciences Company Details
    Table 191. LG Life Sciences Business Overview
    Table 192. LG Life Sciences Liver Diseases Treatment Product
    Table 193. LG Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 194. LG Life Sciences Recent Development
    Table 195. Verva Pharmaceuticals Company Details
    Table 196. Verva Pharmaceuticals Business Overview
    Table 197. Verva Pharmaceuticals Liver Diseases Treatment Product
    Table 198. Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 199. Verva Pharmaceuticals Recent Development
    Table 200. Shenzhen Kangtai Biological Products Company Details
    Table 201. Shenzhen Kangtai Biological Products Business Overview
    Table 202. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product
    Table 203. Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 204. Shenzhen Kangtai Biological Products Recent Development
    Table 205. Raptor Pharmaceuticals Company Details
    Table 206. Raptor Pharmaceuticals Business Overview
    Table 207. Raptor Pharmaceuticals Liver Diseases Treatment Product
    Table 208. Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 209. Raptor Pharmaceuticals Recent Development
    Table 210. ProMetic Life Sciences Company Details
    Table 211. ProMetic Life Sciences Business Overview
    Table 212. ProMetic Life Sciences Liver Diseases Treatment Product
    Table 213. ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 214. ProMetic Life Sciences Recent Development
    Table 215. Phenex Pharmaceuticals Company Details
    Table 216. Phenex Pharmaceuticals Business Overview
    Table 217. Phenex Pharmaceuticals Liver Diseases Treatment Product
    Table 218. Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 219. Phenex Pharmaceuticals Recent Development
    Table 220. Research Programs/Design for This Report
    Table 221. Key Data Information from Secondary Sources
    Table 222. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liver Diseases Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Drugs Features
    Figure 3. Targeted Therapy Features
    Figure 4. Anti-Viral Drugs Features
    Figure 5. Immunoglobulins Features
    Figure 6. Corticosteroids Features
    Figure 7. Vaccines Features
    Figure 8. Anti-Rejection Drugs/Immunosuppressant Features
    Figure 9. Global Liver Diseases Treatment Market Share by Application: 2020 VS 2027
    Figure 10. Cancer Case Studies
    Figure 11. Hepatitis Case Studies
    Figure 12. Cirrhosis Case Studies
    Figure 13. Other Case Studies
    Figure 14. Liver Diseases Treatment Report Years Considered
    Figure 15. Global Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Liver Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Liver Diseases Treatment Market Share by Regions: 2020 VS 2027
    Figure 18. Global Liver Diseases Treatment Market Share by Regions (2022-2027)
    Figure 19. Global Liver Diseases Treatment Market Share by Players in 2020
    Figure 20. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Treatment as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2020
    Figure 22. Global Liver Diseases Treatment Revenue Market Share by Type (2016-2021)
    Figure 23. Global Liver Diseases Treatment Revenue Market Share by Type (2022-2027)
    Figure 24. North America Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Liver Diseases Treatment Market Share by Type (2016-2027)
    Figure 26. North America Liver Diseases Treatment Market Share by Application (2016-2027)
    Figure 27. North America Liver Diseases Treatment Market Share by Country (2016-2027)
    Figure 28. United States Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Liver Diseases Treatment Market Share by Type (2016-2027)
    Figure 32. Europe Liver Diseases Treatment Market Share by Application (2016-2027)
    Figure 33. Europe Liver Diseases Treatment Market Share by Country (2016-2027)
    Figure 34. Germany Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Liver Diseases Treatment Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Liver Diseases Treatment Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Liver Diseases Treatment Market Share by Region (2016-2027)
    Figure 44. China Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Liver Diseases Treatment Market Share by Type (2016-2027)
    Figure 52. Latin America Liver Diseases Treatment Market Share by Application (2016-2027)
    Figure 53. Latin America Liver Diseases Treatment Market Share by Country (2016-2027)
    Figure 54. Mexico Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Liver Diseases Treatment Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Liver Diseases Treatment Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Liver Diseases Treatment Market Share by Country (2016-2027)
    Figure 60. Turkey Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Abbott Laboratories Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 64. Bayer Schering Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 65. Eli Lilly Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 66. Merck Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 67. Novartis Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 69. Roche Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 70. Sanofi-Aventis Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 72. Zydus Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 73. Glaxosmithkline Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 75. General Electric Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 76. Koninklijke Philips Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 77. Siemens Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 78. Canon Medical Systems Corp Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 79. Hitachi Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 80. Elekta Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 81. Neusoft Corporation Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 82. Samsung Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 83. BPL Medical Technologies Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 84. Cura Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 85. Angion Biomedica Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 86. Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 87. Gilead Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 88. LG Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 89. Verva Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 90. Shenzhen Kangtai Biological Products Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 91. Raptor Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 92. ProMetic Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 93. Phenex Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Bayer Schering
Eli Lilly
Merck
Novartis
Pfizer
Roche
Sanofi-Aventis
Takeda Pharmaceutical
Zydus Pharmaceuticals
Glaxosmithkline
Bristol-Myers Squibb
General Electric
Koninklijke Philips
Siemens
Canon Medical Systems Corp
Hitachi
Elekta
Neusoft Corporation
Samsung Healthcare
BPL Medical Technologies
Cura Healthcare
Angion Biomedica
Achillion Pharmaceuticals
Gilead Sciences
LG Life Sciences
Verva Pharmaceuticals
Shenzhen Kangtai Biological Products
Raptor Pharmaceuticals
ProMetic Life Sciences
Phenex Pharmaceuticals
Frequently Asked Questions
Liver Diseases Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liver Diseases Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liver Diseases Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports